Shlomo Meislin Harnas Email & Phone Number

Support pharma, biotech, medtech, and investors on projects that require non-standard, customized approaches combining extensive analytical acumen with in-depth commercial and market knowledge.- Fractional/contract VP, directly supporting CEOs and CCOs with commercial strategy, operational planning, scenario development and modeling/forecasting, cross-functional coordination, and budget - Commercial BD evaluation, diligence, and support for industry and investors (PE, VC)- Business case development and opportunity evaluation, buy-side and sell-side- Advise healthcare and medtech startups on commercial strategy and business planning

New York, Ny, Us

Mid Atlantic Bio Angels group (MABA) is an angel investor group focused on new and emerging life science companies.

Greenwich, Ct, Us

Strategy, development, and BD/diligence advisor for various medical device and health technology startups and development-stage companies, as well as angel investor.

Dallas, Texas, Us

Advise MedTech company on commercial/growth strategy and due diligence prep.

Aachen, De

North America Commercial voice within global organization, reporting directly to the U.S. CEO. Responsible for business planning, acquisition/licensing evaluations, U.S. market entry strategy, and forecasting/analytics on licensed portfolio. Commercial lead for mid-late stage rare/orphan portfolio (Interim).

Chicago, Il, Us

Go-to engagement leader for due diligence and licensing/acquisition support - involved in >70% of the Life Science global practice's due diligence & forecasting projects across pharma, biotech, and medtech, leading teams across 3 continents.Further work on numerous commercial strategy, market entry, and launch planning projects for pharmaceuticals, biologics, vaccines, and medical devices in the US, EU, Latin America, and Asia markets.

Led and executed projects focusing on rare disease, developing markets, and commercial due diligence.Moved to Navigant upon their acquisition of Leerink's consulting group.

Particular focus on new product/portfolio strategy, due diligence and LM&A support, and rare disease. Led teams of 2-5, with consistently high praise for project quality and mentoring. Teamwork award winner.

Cambridge, Ma, Us

Advisors: Dr. Phillip A. Sharp and Dr. Laurie A. Boyer, MIT Department of Biology

Chevy Chase, Maryland, Us

Advisor: Dr. Melissa J. Moore., Howard Hughes Medical Institute and Brandeis University Department of Biochemistry

Boston, Ma, Us

Blue Sky Compliance Department

S.M., Biology

M.S., Biochemistry, B.S. Biology, B.A. Mathematics.